INTERMEDIATE SOLUTION BY INTRA-ARTICULAR INJECTION WITHOUT SURGERY

 

Contact Information
Berna Ozel Guvensan
Strawinskylaan 1143, Amsterdam, The Nether
Istanbul
Select One - 1077 XX
Netherlands
+31 0 62 147 38 46
bozel@vsybiotechnology.com
 
INTERMEDIATE SOLUTION BY INTRA-ARTICULAR INJECTION WITHOUT SURGERY
Osteoarthritis causes reduced movement and pain due to the disruption of the cartilaginous structures on the joint surface. New solutions offer treatments without surgery. One of the most important treatments recently accepted all over the world is intra-articular injection, which slows the progression of osteoarthritis.

Knee, hip, ankle, finger, and spinal joints are the sites in the body most commonly affected by osteoarthritis, and aches and pains occur alongside it. In the following period, it may affect the daily life difficulty walking, climbing stairs, and standing for extended periods. Measures and current treatment methods can slow the progression of osteoarthritis, which is more common in people over 40 years old. The treatments' aim is to improve the quality of life in the long term without joint replacement surgery.

Besides exercise, physical therapy methods, and drug treatments, intra-articular injections are a solution for osteoarthritis patients to prevent the transition to the last stage of the disease, which will require prosthetic surgery, or to postpone surgery for as long as possible

INTRA-ARTICULAR INJECTIONS ARE PRODUCED WITH HIGH TECHNOLOGY BY VSY BIOTECHNOLOGY
Sodium hyaluronate intra-articular injections can only be produced by a few companies in the world, one of which is VSY Biotechnology. As a result of long studies, Reviscon-branded intra-articulatory injection line with international quality standards has been developed by their R&D Center.

VSY Biotechnology is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe. Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems and viscoelastics for ophthalmology and orthopedics. Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 55 countries around the globe from our headquarters with a professional marketing and distribution approach. With our know-how in biotechnology, we will continue to enlighten the world by combining these disciplines for the patients.
For more information, visit: http://www.vsybiotechnology.com/orthopedics/


joint, intra-articulatory injection, reviscon, osteoarthritis

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.